Randomized, placebo-controlled trial of AHCC for the reduction of side effects in breast cancer chemotherapy
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000008143
- Lead Sponsor
- Department of Complementary & Alternative Medicine, Graduate school of Medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)The case who will take in functional food shown as below during FEC75 AgaricusTturmeric,Shark cartilage, Tahibo,Propolis,Shelf fungus,Coenzyme Q10,Vegetable juice,Chlorella,Fomes yucatensis,Fucoidan,Royal jelly,DHA, Aloe,PC-SPES,Saw palmetto,Bracket fungus,Selenium,Beta carotene,Isoflavone,Garlic,Black vinegar,Ginkgo biloba extract,Lactic-acid-bacteria tablet
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is to reduce adverse events during chemotherapy reffered CTCAE ver 4.0.
- Secondary Outcome Measures
Name Time Method